Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis
Status:
Not yet recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
the study is to evaluate the possible efficacy and safety of nitazoxanide as an adjuvant
therapy in the secondary prevention of SBP in patient with cirrhosis.